Myelodysplastic Syndromes - Causes, Symptoms and Treatment Methods

The Myelodysplastic syndromes (MDS) is anstream. Myelodysplastic syndromes occur most
abnormality of the bone marrow, which graduallyoften in older people, but they can occur in
affects the producton of healthy blood cells. Theyounger people. Some younger people with
most common sign is anemia, which means theremyelodysplastic syndromes who are in otherwise
are too few mature red blood cells to carrygood health may be candidates for a bone
oxygen. The immature blood cells, called blasts, domarrow transplant, which may help prolong life.
not function normally and either die in the boneCauses of Myelodysplastic syndromes
marrow or soon after they enter the blood. InThe common causes and risk factor's of
myelodysplastic syndromes, the stem cells do notMyelodysplastic syndromes include the following:
mature into healthy red blood cells, white bloodThe exact cause of Myelodysplastic syndromes is
cells, or platelets. Myelodysplastic syndromes cannot known.
be classified as primary (no known exposure) orViral infections.
secondary as a complication of aggressivePast treatment with chemotherapy or radiation
treatment of other cancers with exposure totherapy.
radiation, alkylating agents, or topoisomerase IICompounds such as benzene.
inhibitors and heavily pretreated patients withSmoking.
autologous bone marrow transplants. Many of theCertain congenital diseases.
blood cells formed are defective. These abnormalPrevious topoisomerase inhibitor (rare)
blood cells are usually destroyed before theyadministration may be a factor.
leave the bone marrow or shortly after enteringSymptoms of Myelodysplastic syndromes
the bloodstream. Each year between 15,000 andSome sign and symptoms related to
20,000 new cases of MDS are diagnosed in theMyelodysplastic syndromes are as follows:
United States. The original classification of MDSAnemia.
was developed more than 20 years ago at anShortness of breath.
international conference attended mostly byBleeding or bruising.
doctors from France, the United States, andFever or frequent infections.
Great Britain. No truly effective treatment existsFever.
for most people with myelodysplastic syndromes,Susceptibility to infections.
and therapy for myelodysplastic syndromesMalaise, and a general feeling of tiredness.
usually focuses on reducing or preventingAbnormal granules in cells, abnormal nuclear shape
complications of the disease and of treatments.and size.
A myelodysplastic syndrome may developChest pain.
following treatment with drugs or radiationTreatment of Myelodysplastic syndromes
therapy for other diseases, or it may developHere is list of the methods for treating
without any known cause. The disease is oftenMyelodysplastic syndromes:
not diagnosed until the patient is seen by aPeople with high risk myelodysplasia may only
hematologist, and cannot be definitively diagnosedneed supportive treatment to help improve any
until a bone marrow sample taken from thesymptoms caused by low blood counts.
patient is examined by an expert hematologist orCentral line access is often needed for
hematopathologist. Many patients withchemotherapy and transfusion.
myelodysplastic syndromes suffer from a varietyTransfusion therapy: People with anemia induced
of symptoms caused by low blood counts. Otherby myelodysplastic syndromes are likely to
patients have no symptoms at all. MDS isreceive transfusions of red blood cells, which help
classified into groups according to findings onrelieve anemia and fatigue.
peripheral blood smear, bone marrow histology,Bone marrow transplantation provides a curative
and clinical findings. The bone marrow inoption for some patients.
myelodysplastic syndrome is typically more activeDrips (transfusions) of blood or platelets can be
than normal and yet the numbers of blood cells ingiven to help improve symptoms.
the circulation are reduced. This is because mostAntibiotics may also be needed to treat or
of the cells being produced in the bone marrowprevent infection. This is often known as
are defective and are destroyed before theysupportive treatment.
leave the bone marrow to enter the blood